Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer

Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer

15 Aug 2023 1:30 PM | Anonymous member (Administrator)

Yuto Kubo MD, PhD, Tomoki Makino MD, PhD, Makoto Yamasaki MD, PhD, Koji Tanaka MD, PhD, Kotaro Yamashita MD, PhD, Osamu Shiraishi MD, PhD, Keijiro Sugimura MD, PhD, Hiroshi Miyata MD, PhD, Masaaki Motoori MD, PhD, Kazumasa Fujitani MD, PhD, Atsushi Takeno MD, PhD, Motohiro Hirao MD, PhD, Yutaka Kimura MD, PhD, Taroh Satoh MD, PhD, Masahiko Yano MD, PhD, Hidetoshi Eguchi MD, PhD, Takushi Yasuda MD, PhD & Yuichiro Doki MD, PhD

Read Abstract: Three-Course Neoadjuvant Chemotherapy Associated with Unfavorable Survival of Non-responders to the First Two Courses for Locally Advanced Esophageal Cancer | SpringerLink


Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software